Immunbiologie chronisch-entzündlicher Darmerkrankungen

Morbus Crohn - Colitis ulcerosa - mukosales Immunsystem

Crohn’s disease - ulcerative colitis - mucosal immune system

Literatur

• 1 Bamias A, Nyce M R, De La Rue S A, Cominelli F. New concepts in the pathophysiology of inflammatory bowel disease.  Ann Intern Med. 2005;  143 895-904
• 2 Elliott D E, Summers R W, Weinstock J V. Helminths and the modulation of mucosal inflammation.  Curr Opin Gastroenterol. 2005;  21 51-58
• 3 Kruis W. Review article: antibiotics and probiotics in inflammatory bowel disease.  Aliment Pharmacol Ther. 2004;  20 (Suppl 4) 75-78
• 4 Mannon P J, Fuss I J, Mayer L. et al . Anti-interleukin-12 antibody for active Crohn’s disease.  N Engl J Med. 2004;  351 2069-2079
• 5 Podolsky D K. Selective adhesion-molecule therapy and inflammatory bowel disease - a tale of Janus?.  N Engl J Med. 2005;  353 1965-1968
• 6 Rutgeerts P, Sandborn W J, Feagan B G. et al . Infliximab for induction and maintenance therapy for ulcerative colitis.  N Engl J Med. 2005;  353 2462-2476